Arsenic-based antineoplastic drugs and their mechanisms of action.
about
Metalloid compounds as drugsCandidate single nucleotide polymorphism markers for arsenic responsiveness of protein targetsPosttranslational modification of human glyoxalase 1 indicates redox-dependent regulationAn arsenic fluorescent compound as a novel probe to study arsenic-binding proteins.Inhibitor of kappaB kinase beta regulates redox homeostasis by controlling the constitutive levels of glutathioneGenetic basis of arsenite and cadmium tolerance in Saccharomyces cerevisiae.Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism.Mitochondrial proteomics of nasopharyngeal carcinoma metastasisHigh-throughput Giardia lamblia viability assay using bioluminescent ATP content measurementsDiscovery of novel antigiardiasis drug candidates.Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide.Genomic analysis of stress response against arsenic in Caenorhabditis elegans.Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism.Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxideBiological responses to arsenic compoundsZinc finger proteins as templates for metal ion exchange and ligand reactivity. Chemical and biological consequences.Therapeutic and analytical applications of arsenic binding to proteins.Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexesRho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells.Remodulation of central carbon metabolic pathway in response to arsenite exposure in Rhodococcus sp. strain NAU-1.The inositol pyrophosphate pathway in health and diseases.
P2860
Q26822682-0D1FB314-AE64-45DC-B71C-F0A8B1CAE378Q28384163-09ACF2DA-B072-4382-9E85-D236E25549EDQ28473799-1DA73F15-0E4D-49DF-817A-E3D588D40313Q30420808-69FD007B-ACF5-420D-AD9F-7E53733FB2D2Q30475693-20E2A0B4-6CE9-48B8-8BAC-791241F75A0BQ33417918-B50AA216-6DF5-44CE-A951-1670AC6331EAQ33470967-46141C46-EDED-4B7E-B651-59D20736BD66Q34502955-0C555C8F-D66B-47EB-BD7F-991B2C510326Q34529169-DE3FA662-5E00-4F14-9157-13942BC425A0Q34597506-27D637DC-B8D7-4304-A950-75F176551569Q34727862-476E334A-8A62-44BC-AA8B-7D5B7B300445Q34872369-0B3F691B-221D-4893-B507-A9EAB4643B55Q35147292-D07C192F-331A-49BA-8E2F-C31B8DE0CCB7Q35618400-C80DC2B5-20BB-47B1-9CE9-EE346DDB716FQ36352545-FE3B9E4C-B427-4B66-91C5-E6B3C7491415Q37442397-8AA69B31-8DA7-4E70-B946-7C13F48ED157Q37831171-A5A05F0D-D8DF-44D0-BBCE-80F6F0405284Q38263881-7FC29470-5E37-4FD9-B57D-9EA7A6B8F5C5Q38358175-4A5891AF-5101-4FB2-BB09-2727B5C787BBQ39036566-51E0BA00-AACB-40A6-8C06-D93150643DF0Q39095650-AA27F828-A049-4980-B51C-D3C428773929Q39175196-444862E7-EF98-48CD-A1DA-D5455D7F99CDQ41977384-88BFC00D-4559-4F7F-B527-26878542DD02Q47250401-E79990B8-0F0C-4542-B924-213A09F89165
P2860
Arsenic-based antineoplastic drugs and their mechanisms of action.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Arsenic-based antineoplastic drugs and their mechanisms of action.
@en
Arsenic-based antineoplastic drugs and their mechanisms of action.
@nl
type
label
Arsenic-based antineoplastic drugs and their mechanisms of action.
@en
Arsenic-based antineoplastic drugs and their mechanisms of action.
@nl
prefLabel
Arsenic-based antineoplastic drugs and their mechanisms of action.
@en
Arsenic-based antineoplastic drugs and their mechanisms of action.
@nl
P2860
P356
P1433
P1476
Arsenic-based antineoplastic drugs and their mechanisms of action.
@en
P2093
Stephen John Ralph
P2860
P304
P356
10.1155/2008/260146
P577
2008-01-01T00:00:00Z